本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ultragenyx Pharmaceutical Inc

14.92
-0.3800-2.48%
盘后:15.040.1200+0.80%19:55 EDT
成交量:530.63万
成交额:7,912.21万
市值:14.67亿
市盈率:-2.56
高:15.39
开:15.27
低:14.69
收:15.30
52周最高:39.89
52周最低:12.73
股本:9,831.72万
流通股本:8,071.56万
量比:1.38
换手率:6.57%
股息:- -
股息率:- -
每股收益(TTM):-5.8279
每股收益(LYR):-5.8316
净资产收益率:-608.47%
总资产收益率:-24.22%
市净率:-5.04
市盈率(LYR):-2.56

数据加载中...

2020/03/06

重要事件披露

8-K - Current report
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/13

重要事件披露

Current report, items 2.02 and 9.01
2020/02/13

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/06

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/13

重要事件披露

Current report, items 2.02, 7.01, 8.01, and 9.01
2020/01/09

重要事件披露

Current report, items 7.01, 8.01, and 9.01
2020/01/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/18

重要事件披露

Current report, item 1.01
2019/11/25

重要事件披露

Current report, items 5.02 and 9.01
2019/11/06

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/05

重要事件披露

Current report, items 2.02 and 9.01
2019/10/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals